Evidence-Based Management of Box Jellyfish Stings.

Area of Science:

• Marine toxicology
• Emergency medicine
• Dermatology

Background:

• Box jellyfish stings pose severe health risks, especially to military personnel in aquatic environments.
• Current first-aid measures often fail to neutralize cubozoan venom, leading to significant tissue damage and systemic effects.
• There is an urgent need for effective and rapidly acting treatments for box jellyfish envenomation.

Purpose of the Study:

• To compare the efficacy of established first-aid interventions against novel copper gluconate (CuGluc)-based treatments for box jellyfish stings.
• To evaluate the ability of various treatments to inhibit venom-induced hemolysis and tissue damage in vitro and in vivo.

Main Methods:

• Comparative analysis of first-aid methods including vinegar, hot/cold packs, and topical agents.
• Assessment of novel copper gluconate (CuGluc) formulations.
• Utilized in vitro hemolytic assays, live-tentacle sting models on porcine skin, and an in vivo anesthetized piglet model.

Main Results:

• Sequential application of CuGluc spray and cream demonstrated superior efficacy in mitigating sting-induced hemolysis and tissue damage across all tested models.
• Vinegar dousing followed by heat application showed moderate effectiveness in inhibiting venom activity.
• Traditional methods like saltwater rinses and ice packs proved ineffective and exacerbated tissue damage.

Conclusions:

• Topical copper gluconate (CuGluc) formulations represent the most effective treatment for box jellyfish stings currently available.
• CuGluc treatments significantly reduce cubozoan venom-associated tissue damage compared to all other evaluated first-aid approaches.
• These findings offer a critical advancement in managing severe marine envenomations.